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Objective: Implementing national-level vaccination programs involves long-term investment, which can
be a significant financial burden, particularly in resource-limited settings. Although many studies have
assessed the economic impacts of providing vaccinations, evidence on the positive and negative implica-
tions of human resources for health (HRH) is still lacking. Therefore, this study aims to estimate the HRH
impact of introducing pneumococcal conjugate vaccine (PCV) using a model-based economic evaluation.
Methods: This study adapted a Markov model from a prior study that was conducted in the Philippines
for assessing the cost-effectiveness of 10-valent and 13-valent PCV compared to no vaccination. The
Markov model was used for estimating the number of cases of pneumococcal-related diseases, catego-
rized by policy options. HRH-related parameters were obtained from document reviews and interviews
using the quantity, task, and productivity model (QTP model).
Results: The number of full-time equivalent (FTE) of general practitioners, nurses, and midwives
increases significantly if the universal vaccine coverage policy is implemented. A universal coverage of
PCV13 - which is considered to be the best value for money compared to other vaccination strategies -
requires an additional 380 FTEs for general practitioners, 602 FTEs for nurses, and 205 FTEs for midwives;
it can reduce the number of FTEs for medical social workers, paediatricians, infectious disease specialists,
neurologists, anaesthesiologists, radiologists, ultrasonologists, medical technologists, radiologic technol-
ogists, and pharmacists by 7, 17.9, 9.7, 0.4, 0.1, 0.7, 0.1, 12.3, 2, and 9.7, respectively, when compared to
the no vaccination policy.
Conclusion: This is the first attempt to estimate the impact of HRH alongside a model-based economic
evaluation study, which can be eventually applied to other vaccine studies, especially those which inform
resource allocation in developing settings where not only financial resources but also HRH are
constrained.
 2016 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction inefficient use of human resources or imbalance in the compositionHuman resources are an integral part of every healthcare sys-
tem [1]. However, in low- and middle-income countries (LMICs),
human resources for health (HRH) are often limited, which impacts
both the access to and quality of healthcare [1,2]. The shortage of
healthcare workers can be due to different factors such as low pro-
duction capacity for HRH, brain drain of healthcare workers,of demographics [3,4]. As the demand for healthcare services
increases, this scarcity can result in instability of the healthcare
system. In addition, introducing health interventions or technolo-
gies will always have an effect on the demand for human resources
and this should be a serious concern for decision-makers, espe-
cially in LMICs, as training health workforce (i.e. general practition-
ers and medical specialists) requires a considerable amount of time
[5–7].
Vaccination can be considered as a unique intervention in the
context of human resources. Vaccination programs are a long-
term investment for preventing specific diseases, and have a
dynamic effect on the utilization of different types of HRH.
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types of human resources and reduce the future need of the health
workforce in treating vaccine preventable diseases [8,9]. Although
there are few papers addressing the success of vaccination in terms
of HRH requirements [2,10], no study has been conducted that
compares the impact of vaccinations in terms of both HRH needed
and reduced within a study.
It would be appropriate for evidence-informed policy decisions
to take into account both HRH required and saved due to vaccina-
tions. Therefore, this study aims to take this challenge by estimat-
ing the HRH needed and reduced as a result of introducing the
pneumococcal conjugate vaccine (PCV). This study is conducted
as an additional analysis to the economic evaluation using the
Philippines as a case study due to their existing economic model
which compares various vaccination policy options [11].Fig. 1. Summary of the four steps in HRH estimation.2. Material and methods
This study examines the impact of HRH by using the quantity,
task, and productivity (QTP) model. The QTP model is one of the
approaches to determine HRH and was developed under the con-
cept of functional job analysis whereby the skill requirements to
complete a certain task are assessed [12]. There are four main
key features of this model: (1) it includes a set of priority interven-
tions, (2) it estimates HRH by calculating the number of cases
needed for a service (service quantity), (3) it identifies the tasks
and estimates the time needed to deliver a service, and (4) it
includes the productivity by combining staff productivity and ser-
vice productivity. This model has been developed for low-income
countries that want to scale up their priority interventions. A study
conducted by Kurowski et al. showed that the QTP method was
robust in estimating the required human resources [13].
Furthermore, this model is practical and feasible for application
in the Philippines where data resources are restricted. The adapted
version of the QTP model for estimating the HRH impact of intro-
ducing the PCV vaccination in the Philippines is shown in Supple-
ment A. Using this model, the HRH-related parameters were
obtained from existing clinical practice guidelines [14–17] wherein
the applicability of each procedure in the local setting was verified
by conducting interviews with healthcare providers. The adapted
QTP model includes four major steps (Fig. 1) and is described in
the following paragraphs.
In the first step, several health services for the treatment of
pneumococcal-related diseases were identified, including the
number of cases that occurred in each scenario, i.e. with and with-
out the vaccination program. The number of cases for each disease
was estimated using the Markov model from a prior economic
evaluation study that was conducted in the Philippines [11].
One-year time horizon was employed in this study, while the prior
economic evaluation used a Markov model with a lifetime horizon.
The target population for universal coverage of the PCV vaccination
was set at 2,200,000 eligible infants below the age of one year
based on 2013 data obtained from the Philippine Statistics Author-
ity [18].Number of healthcare workers ðin FTEsÞ ¼ Total time spent of healthcare pro
Total workingIn the second step, the types of health workforces needed for
each type of health service relating to vaccination, treatments of
non-hospitalized pneumonia, and acute otitis media were obtained
based on consensus among municipal health officers in the semi-
nar for the primary care benefit package of the state insurance
scheme; meanwhile, data on treatment of meningitis, sepsis/bac-
teraemia and hospitalized pneumonia in intensive care units
(ICU) and non-ICUs were derived from four medical specialists. In
the data collection process, participants were given information on
healthcare services as stated by the clinical practice guidelines
from the Philippine Health Insurance Corporation [14]; Philippine
Clinical Practice Guidelines on the Diagnosis, Empiric Manage-
ment, and Prevention of Community-acquired Pneumonia (CAP)
in Immunocompetent Adults [15]; and Integrated Management
of Childhood Illness (IMCI) [16,17]. After that, they were asked to
indicate the set of healthcare services they provide in their prac-
tice, followed by identifying the types of health workforce needed
as well as the average amount of time (minutes) for each health
professional spent per treated patient or vaccinated child.
In the third step, the magnitude of HRH needed for each policy
option was estimated. Staff productivity was assumed to be 6 h or
360 min per day, with 220 working days in a year. The number of
healthcare workers needed for the implementation of the PCV vac-
cination and for the treatment of pneumococcal-related diseases
was calculated in full-time equivalent (FTE) using the formula
below. One FTE equals one employee that works on a full-time
basis. In the last step, HRH needed and reduced were compared
with each other for each policy option.vider per case ðminutesÞ  Number of cases or target population
time per year ð¼ 360  220 min=person=yearÞ
Table 1
Number of cases receiving health care services by policy options.
Types of health care
services
Policy options
1 2 3 4 5
No
vaccination
program
PCV10 with 25% coverage of
vaccination program
PCV10 with 100% coverage of
vaccination program
PCV13 with 25% coverage of
vaccination program
PCV13 with 100% coverage
of vaccination program
Vaccination 0 550,000 2,200,000 550,000 2,200,000
Meningitis treatment 3331 3305 2807 3295 2747
Sepsis/ Bacteremia
treatment
3260 3247 2679 3242 2612
Hospitalized
pneumonia
treatment
327,714 326,947 323,592 326,654 322,272
Non-hospitalized
pneumonia
treatment
218,476 217,965 215,728 217,769 214,848
Acute otitis media
treatment
2,550,431 2,541,432 2,514,437 2,537,981 2,500,631
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Based on five available policy options (no vaccination program,
PCV10 with 25 percent coverage, PCV10 with 100 percent
coverage, PCV13 with 25 percent coverage, and PCV13 with 100
percentage coverage), Table 1 illustrates six types of healthcare
services that are related to the prevention or treatment of
pneumococcal-related diseases: vaccination, meningitis treatment,
sepsis/bacteraemia treatment, hospitalized pneumonia treatment,
non-hospitalized pneumonia treatment, and acute otitis media
treatment. Regardless of the vaccination program, the demand
for acute otitis media treatment is the highest, followed by the
pneumonia treatment. Implementing the PCV10 or PCV13 would
reduce the number of the aforementioned vaccine-preventable
conditions. The higher the vaccination coverage, the lower the
number of patients treated.
Table 2 presents the average amount of time that each type of
health professional spends per treated patient or vaccinated child.
The average time spent per case is the highest for the treatment of
meningitis by paediatricians, which equals 746.50 min per case.
The lowest average time spent per care is for midwives, which is
only 5 min for non-hospitalized pneumonia and acute otitis media
treatment, and for radiologists, which is 5 min for both hospital-
ized and non-hospitalized pneumonia treatment.
Further, the number of healthcare professionals needed for each
policy option was identified in Table 3. This table and Fig. 2 show
the increase and reduction of FTEs for each type of healthcare pro-
fessionals required for the treatment of pneumococcal-related dis-
eases resulting from the implementation of the PCV vaccination
policy. It can be seen that the implementation of the PCV vaccina-
tion significantly increases the number of general practitioners,
nurses, and midwives required for the vaccination program.4. Discussion
This is the first attempt to estimate the impact of HRH alongside
a model-based economic evaluation study, which can be eventu-
ally applied to other studies, especially those that inform resource
allocation in developing settings where not only financial
resources but HRH are also constrained. This study is different
from economic evaluations, which focus only on comparisons
between costs and outcomes (Incremental Cost-Effectiveness
Ratio; ICER). Although economic evaluation guidelines recommend
reporting costs and resources used separately [19,20], only few
papers do this [21,22] and even fewer papers report resources usedby giving detailed information of health workforce. This HRH study
is a complementary analysis and the results are reported as HRH
saved and needed (in terms of FTE). The results showed that the
number of FTEs for GPs, nurses, and midwives increases signifi-
cantly if the universal vaccination coverage policy is implemented.
Nevertheless, the vaccination program can avert HRH requirement
for specialized healthcare professionals who require longer term
training and are more restricted compared to GPs, nurses, and mid-
wives in the Philippines [23]. Moreover, the salary of GPs, nurses,
and midwives are likely to be lower than those specialized health-
care professionals.
An associated cost-effectiveness analysis found that the univer-
sal coverage for PCV13 has the lowest ICER compared to no vacci-
nation amongst the four vaccination strategies [11]. Although this
policy needs an additional 380 FTEs for general practitioners, 602
FTEs for nurses, and 205 FTEs for midwives, it can reduce the num-
ber of FTEs for medical social workers, paediatricians, infectious
disease specialists, neurologists, anaesthesiologists, radiologists,
ultrasonologists, medical technologists, radiologic technologists
and pharmacists by 7, 17.9, 9.7, 0.4, 0.1, 0.7, 0.1, 12.3, 2, and 9.7,
respectively, when compared to the no vaccination policy. From
the analysis can also be observed that HRH requirements for both
PCV10 and PCV13 were very similar, meaning that choosing PCV13
over PCV10 would not have differed in terms of HRH impact. This
type of information should be presented to decision-makers so that
they can make an appropriate and feasible policy choice, taking
into account not only cost-effectiveness evidence and budget
impact but also impact on HRH, which cannot be increased within
a short period of time. Neglecting information on HRH when intro-
ducing any large health programs, including vaccination, can put
the policy at high risk of failure due to the overburden of existing
healthcare workers.
If the estimated HRH required seems infeasible for implement-
ing a universal vaccination program, a proper plan for task shifting
of vaccination activities – i.e. physical examinations that are being
carried out by GPs - to nurses, midwives, and pharmacists should
be investigated. Meanwhile, FTEs of specialized healthcare profes-
sionals freed up by the vaccination program can be used for other
health policies. In addition, it is interesting to note that only a rel-
atively small reduction of FTEs among specialized healthcare work-
ers from the vaccination program was observed in this study. An
explanation could be that in the Philippines, there is a severely lim-
ited number of these specialists and they are working under high
workloads, resulting in limited time spent for each patient treated.
The prevention of pneumococcal-related diseases from the vacci-
nation means that they can spend a longer time providing better
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S. Chootipongchaivat et al. / Vaccine 34 (2016) 4814–4819 4817care for patients. Although this study did not investigate whether
the current time allocated to the treatment of pneumococcal-
related diseases was appropriate, the current estimates indicate
that the quality of care may be less than optimal due to shortages
of key staff.
This study has some limitations. Firstly, the profile (type) and
magnitude (time spent) of health professionals required for each
service are specific to the context of the Philippines; therefore,
the use of this study’s results for other settings needs to be per-
formed with caution. Secondly, the study focuses on the impact
of HRH at the national level. However, the aforementioned HRH
may not be distributed equally across geographical locations, espe-
cially between urban and rural areas [24]. It would be necessary to
estimate the HRH impact for each province when introducing the
vaccination policy in order to ensure that HRH planning is ade-
quate across sub-national levels. Thirdly, this study only consid-
ered a one-year time horizon despite the fact that previous
evidence suggested that the vaccine may be able to prevent
pneumococcal-related diseases for up to 5 years after vaccination
[25], which may result in an underestimation of HRH freed up by
the vaccine program. However, this study already included herd
protection for universal vaccination coverage but not for 25 per-
cent coverage. Lastly, this study employed an expert opinion
approach for data collection on the number of minutes used by
health professionals in treating each child and this can be problem-
atic in terms of robustness. Although experts were requested to
discuss about the estimates among their peers in order to ensure
that the provided numbers were feasible, this might not be an ideal
approach. With this regard, it is recommended for future study to
conduct a prospective observational data collection. The benefit of
collecting primary data from observation is that a probabilistic
sensitivity analysis can be performed to assess the uncertainty
on parameters.
There are two interesting points for further study: 1) to explore
the effects of adherence to clinical practice guidelines for physi-
cians on estimating HRH in comparison to real practice, and 2)
to consider whether there is a need for discounting if the HRH
impact is estimated beyond a one-year time horizon. For example,
when implementing the human papilloma virus (HPV) vaccination
program at present, the effects on HRH (e.g., cervical oncologists)
will occur in the next twenty or thirty years. In such case, it is
questionable whether the effects on HRH in the future should be
discounted similarly to the standard practice in economic evalua-
tions that discounts further costs and outcomes [19]. Furthermore,
the future impact of technology and innovation will have
unknown implications on the HRH required in terms of health
management. Any adjustments for predicted HRH in the future
may introduce considerable uncertainty and may limit future
HRH planning.5. Conclusions
This study examines an approach for estimating HRH impact
alongside economic evaluation studies on PCV vaccination policy
in the Philippines. It illustrates the importance of HRH impact esti-
mations to inform policy decisions in resource-limited settings;
this is to ensure that comprehensive evidence was used to formu-
late policy choice for decision makers. The study informs the
reduction of specialized healthcare professionals for treatment of
pneumococcal-related diseases vis-a-vis the increase of HRH
requirement among GPs, nurses, and midwives as a result of imple-
menting a PCV vaccination program. The authors conclude that the
HRH impact should be estimated to inform priority setting for a
vaccination program.
Table 3
Number of full time equivalent for each type of health care worker for each policy option.
Types of health
care worker
Policy options
1 2 3 4 5
No
vaccination
program
PCV10 with 25% coverage of
vaccination program
PCV10 with 100% coverage of
vaccination program
PCV13 with 25% coverage of
vaccination program
PCV13 with 100% coverage of
vaccination program
Medical Social
Worker
348.5 347.4 341.5 347.7 343.0
General
Practitioner
1890.6 1985.9 2271.0 1988.4 2280.9
Pediatrician 961.1 956.6 943.2 957.9 948.2
IDS 263.9 263.9 254.2 263.9 255.0
Neurologist 2.5 2.4 2.0 2.5 2.1
Anesthesiologist 0.6 0.6 0.5 0.6 0.5
Radiologist 34.9 34.8 34.2 34.8 34.4
Ultrasonologist 0.6 0.6 0.5 0.6 0.5
Medical
Technologist
563.3 561.5 551.0 562.0 553.5
Radiologic
Technologist
116.2 115.8 114.2 115.9 114.7
Pharmacist 421.9 420.3 412.2 420.7 414.2
Nurse 1185.9 1340.3 1787.9 1341.6 1793.7
Midwife 174.8 226.1 379.8 226.3 380.7
Fig. 2. Additional HRH needed and reduced.
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